Adar Poonawalla, CEO of Serum Institute of India (SII), expects the world to go back to the pre-Covid times by this time next year. At a global level, he said it would take a year to reach a stage of normality where no testing or precautions were required.
In comparison, India was in a good position as it had made huge strides in vaccinating a large population in such a small amount of time. “We are now very close to turning the tide on the pandemic,” Poonawalla said. However, he cautioned against early celebrations.
Poonawalla was speaking at the ‘FICCI HEAL 2021’ organised jointly with the ministry of health and family welfare and the NITI Aayog, after winning the Healthcare Personality of the Year award at the FICCI Healthcare Excellence Awards on Wednesday.
The award was a validation of all the risks and decisions taken in 2020 in building capacity, finding the right partner and scaling up, Poonawalla said. This takes a lot of time and very few companies in the world were able to scale up fast and that was because of the calculated risks and decisions taken at the start of the pandemic, he added.
The country had administered 87.60 crore doses of SII’s Covishield Covid-19 vaccine till Wednesday.
- 116 more test COVID positive at Karnataka’s medical college - November 26, 2021
- Slip Disc Surgery performed on awake patient - November 26, 2021
- Serum Institute resumes COVID-19 vaccine exports - November 26, 2021
- Mild third wave of COVID-19 pandemic likely in December: Maharashtra Health Minister Rajesh Tope - November 25, 2021
- Putin tests experimental nasal vaccine against COVID-19 - November 25, 2021
- Italy targets unvaccinated with restrictions as cases rise - November 25, 2021
- 59% of employees in India report feeling stressed in everyday life - November 23, 2021
- Capital records 7,128 dengue cases, highest in six years - November 23, 2021
- Covid-19: Tamil Nadu reports 750 new cases - November 23, 2021
- EU considers booster doses of J&J’s COVID-19 vaccine - November 23, 2021